Important information
1 The target equity IRR is +13% per annum over the Fund's five-year Investment Period (after fees and expenses, excluding performance fees).
2 The Total Distribution target and total return target are targets only and are based on a range of assumptions, including those set out in the IM. A range of factors are relevant including many outside the control of the Responsible Entity and Manager. The Fund may not achieve these returns. Please see the IM for further details, including assumptions and the relevant risks associated with an investment in the Fund).
3 As at 30 June 2026.
4 Tenant is wholly-owned subsidiary of Sonic Healthcare.
+13% p.a.
100% triple-net leases
7.5% p.a. (comprising income and capital)
100%
2.0% bonus Wholesale Units
20 years
The Fund is a fixed-term (five-year) unlisted property fund. An investment in the Fund is illiquid.
Important information:
1 All metrics are as at 30 June 2026 (unless otherwise stated).
2 The target equity IRR is +13% per annum over the Fund's five-year Investment Period (after fees and expenses, excluding performance fees).
3 The Total Distribution target and total return target are targets only and are based on a range of assumptions, including those set out in the IM. A range of factors are relevant including many outside the control of the Responsible Entity and Manager. The Fund may not achieve these returns. Please see the IM for further details, including assumptions and the relevant risks associated with an investment in the Fund.
4 Under the Limited Offer, Applicants whose application monies form part of the first $30,000,000 (or such other amount as the Responsible Entity determines) received by the Responsible Entity and in respect of which no Equity Raising Fee is payable in connection with their application, may receive 2.0% bonus Wholesale Units.
5 Triple-net leases meaning the tenant is responsible for the outgoings and capital expenditure in addition to the rent payable.
Under a Limited Offer, Applicants whose application monies form part of the first $30 million received, will receive 2.0% bonus Wholesale Units.*
* Under the Limited Offer, Applicants whose application monies form part of the first $30,000,000 (or such other amount as the Responsible Entity determines) received by the Responsible Entity and in respect of which no Equity Raising Fee is payable in connection with their application, may receive 2.0% bonus Wholesale Units.
LSF provides access to a world-class, integrated pathology diagnostic facility that is essential to Australia’s diagnostic services network.
LSF offers high-net-worth investors access to a high-quality life sciences property leased to Sonic Healthcare, a global leader in medical diagnostics. Supported by a long-term lease, CPI-linked rental growth and a triple-net lease structure**, LSF is designed to provide investors with exposure to institutional-grade real estate and the essential life sciences sector, which benefits from strong long-term demand drivers including an ageing population and increasing healthcare needs.
** Triple-net leases meaning the tenant is responsible for the outgoings and capital expenditure in addition to the rent payable.
In Australia, life sciences infrastructure is supported by strong structural demand drivers and essential service characteristics. Demand is underpinned by long-term demographic trends, including an ageing population, as well as higher testing volumes driven by advances in diagnostics and early detection.
The sector provides essential, non-discretionary services with demand that is resilient through economic cycles and supported by government funding, such as Medicare. At the same time, supply remains constrained due to the sophisticated nature of facilities, high capital requirements and regulatory barriers.
Combined with a concentrated operator landscape and limited availability of fit-for-purpose assets leased to tenants with strong financials and balance sheets, these factors support favourable long-term supply-demand dynamics and continued sector growth.
Learn more about the life sciences opportunity
This website is issued by Charter Hall Direct Property Management Limited ABN 56 073 623 784 AFSL 226849 (CHDPML) as the issuer of units in the Charter Hall Direct Life Sciences Fund (Fund) (Fund). The Information Memorandum (IM) for the Fund is available at www.charterhall.com.au. An investment is subject to risks which are summarised in the IM (Offer Document). You should consider the Offer Document and any supplementary Offer Document in deciding whether to acquire or continue to hold the product. This website is not an offer of units in the Fund or an offer to buy or sell any financial product and should not be relied on in making an investment decision. The information is general in nature and does not take into account your investment objectives, particular needs or financial situation. You should seek independent financial advice. Applications to invest can only be made using the application form relevant to the product. You can obtain a copy of the Offer Document and application form from www.charterhall.com.au or by calling 1300 652 790. You can only apply to invest in the Fund if you are a wholesale client (within the meaning of that term under the Corporations Act 2001 (Cth)). Whilst all care has been taken in preparation of this website CHDPML does not give any representation or warranty as to the reliability, completeness or accuracy of the information contained in this website. CHDPML does not accept liability for any inaccurate, incomplete or omitted information of any kind or any losses caused by using this information. Past performance is not a reliable indicator of future performance. Any forward-looking statement on this website is predictive in character and may be affected by inaccurate assumptions or by known or unknown risks and uncertainties and may differ materially from results ultimately achieved. All figures on this website are as at 30 June 2026 and in Australian dollars unless otherwise stated. © Charter Hall Group.
Charter Hall is Australia’s leading fully integrated diversified property investment and funds management group. We use our expertise to access, deploy, manage and invest equity to create value and generate superior returns for our investor customers. We’ve curated a diverse portfolio of high-quality properties across our core sectors – Office, Industrial & Logistics, Retail and Social Infrastructure. With partnerships and financial discipline at the heart of our approach, we create and invest in places that support our customers, people and communities to grow.
The strength of our strategy, the depth of our partnerships and drive of our people has underpinned our ability to outperform over the long-term. And we continue to have a relentless focus on outperformance for our fund investors.
Charter Hall Direct, part of Charter Hall Group, is one of Australia’s leading direct property fund managers for SMSFs, high net worth individuals and retail investors. We have a strong track record of managing unlisted property funds through all market cycles, since 1995.
View our other funds on Investment Markets:
Important information:
^^ You can only apply to invest in a Wholesale Fund if you are a wholesale client (within the meaning of that term under the Corporations Act 2001 (Cth)).
To receive the Information Memorandum please complete the form on the right (if viewing on desktop) or the form below (if viewing on mobile).
This offer of scheme interests is available to wholesale clients only. This product listing was vetted by and approved by the product issuer identified above before publishing. Investment Markets (Aust) Pty Ltd AFSL 527875 (IM) is not the issuer of the product.
IMPORTANT STATEMENT ABOUT YOUR USE OF THIS SITE
Information on this site is intended for Australian users only.
This site is operated by Investment Markets (Aust) Pty Ltd. (ACN 634 057 248) (IMA, we, us and our), the holder of Australian Financial Services Licence (AFSL) no. 527875. The content is provided solely for information purposes, is not a recommendation or an offer to buy or sell a security, and is not warranted to be correct, complete or accurate. To the extent permitted by law, neither IMA, its affiliates, nor the content providers (such as the issuers of securities who appear on the site) are responsible for any investment decisions, damages or losses resulting from, or related to, the content, data and analyses or their use. The investment products on this site and any statements made about them by their issuers are not vetted, verified or researched by IMA. The presence of an investment product on this site should not be interpreted as an implied endorsement of it by IMA. Certain content provided may constitute a summary or extract of another document such as a Product Disclosure Statement. To the extent any content is general advice, it has been prepared by IMA. Any general advice has been provided without reference to your investment objectives, financial situations or needs. For more information refer to our Financial Services Guide. To obtain advice tailored to your situation, contact a financial advisor. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (or other offer document) before making any decision to invest. Past performance does not necessarily indicate an investment product’s future performance. The content is current as at date of initial publication and may not be current as at your date of viewing. For a more complete understanding of all the terms and conditions of your use of this site click here.